Methods and devices for the sustained release of multiple drugs
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61F-006/14
A61F-006/06
출원번호
UP-0125571
(2008-05-22)
등록번호
US-7838024
(2011-01-22)
발명자
/ 주소
Ron, Eyal S.
Langer, Robert S.
Crowley, Jr., William F.
출원인 / 주소
The General Hospital Corporation
Massachusetts Institute of Technology
대리인 / 주소
Nutter McClennen & Fish LLP
인용정보
피인용 횟수 :
15인용 특허 :
85
초록▼
The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments further comprises a pharmaceuti
The invention relates to an drug delivery device and a method for delivering multiple drugs over a prolonged period of time. The drug delivery device has two or more unitary segments comprising a drug-permeable polymeric substance, wherein at least one of the segments further comprises a pharmaceutically active agent. The invention also relates to a method for the treatment of a benign ovarian secretory disorder in a female mammal, a method of contraception, and a method of relieving the symptoms associated with menopausal, perimenopausal and post-menopausal periods in a woman.
대표청구항▼
We claim: 1. A drug delivery system for the simultaneous release of a drug from two or more segments, comprising: an implantable ring-shaped body comprising two or more arc-shaped segments having terminal ends mated to one another, at least two of the two or more segments being a homogenous mixture
We claim: 1. A drug delivery system for the simultaneous release of a drug from two or more segments, comprising: an implantable ring-shaped body comprising two or more arc-shaped segments having terminal ends mated to one another, at least two of the two or more segments being a homogenous mixture of a drug-permeable polymeric substance comprising ethylene-vinyl acetate copolymer and a drug such that the at least two segments are configured to release the drug at a substantially zero-order rate, wherein each segment has no membrane and is exposed on all sides of an outer surface extending between the terminal ends of the segment. 2. The drug delivery system of claim 1, wherein at least two of the segments comprise a different drug. 3. The drug delivery system of claim 1, wherein the drug is a hormone replacement steroid. 4. The drug delivery system of claim 1, wherein the drug is a contraceptive agent. 5. The drug delivery system of claim 1, wherein the drug is selected from the group consisting of: interferon, anti-angiogenesis factors, growth factors, hormones, enzymes, transferases, hydrolases, lysases, isomerases, proteases, ligases and oxidoreductases, enzyme inhibitors, steroids, anti-cancer drugs and antibiotics. 6. The drug delivery system of claim 1, wherein the drug is selected from the group consisting of: growth hormone, polysaccharides, antigens, and antibodies. 7. A drug delivery system, comprising: an implantable body having a plurality of segments, each segment having first and second terminal ends that are each coupled to a terminal end of an adjacent segment, at least two of the segments being a homogenous mixture of a drug-permeable polymeric substance comprising ethylene-vinyl acetate copolymer and a drug such that the at least two segments are configured to release the drug at a substantially zero-order rate, and wherein each of the at least two segments has no membrane and is exposed on all sides 360° around a perimeter thereof to allow for release of the drug in all directions therefrom. 8. The drug delivery system of claim 7, wherein each segment has a cross-sectional diameter substantially identical to a cross-sectional diameter of the implantable body. 9. The drug delivery system of claim 7, wherein the implantable body is ring-shaped, and each segment comprises an arc of the ring.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (85)
Lovas Sandor (Omaha NE) Conlon J. Michael (Omaha NE) Vincze Borbala (Budapest HUX) Palyi Istvan (Budapest HUX) Gaal Dezso (Budapest HUX) Kalnay Adrienn (Budapest HUX) Mezo Imre (Budapest HUX) Teplan , Anti-tumor effects of GnRH-III.
Mahashabde Anu ; Kay Martha Francine ; Mestichelli Louis J. ; Gooding Ann Elizabeth ; Ruth Suzanne Wilford, Apparatus and method for anesthetizing the cervical region of a female.
Chen Guohua ; Lautenbach Scott ; Dionne Keith ; Hom Lawton, Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents.
Chandrashekar Bhagya L. ; Zhou Mingxing ; Jarr Eileen M. ; Dunn Richard L., Controlled release liquid delivery compositions with low initial drug burst.
Wong Patrick S. L. (Palo Alto CA) Pharriss Bruce B. (Palo Alto CA), Delivery system with mated members for storing and releasing a plurality of beneficial agents.
Merida A. D'Augustine ; James H. Liu ; Donald C. Harrison, Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections.
Goldin Stanley M. (Lexington MA) Mahanthappa Nagesh K. (Cambridge MA) Sudhalter Judith (Newton Lower Falls MA) Fine Eric (Lausanne CHX), Device for delivery of substances and methods of use thereof.
Teillaud Eric (Talant FRX) Sawaya Antoine (Dijon FRX) Math Marie-Christine (Talant FRX), Eva-based transdermal matrix system for the administration of an estrogen and/or a progestogen.
Cheskin Howard ; Hale Thomas J. ; Van Scoik Kurt G. ; Zhou Ji, Homogeneous mixtures of low temperature-melting drugs and additives for controlled release.
Brodman Michael L. (Great Neck NY) Kirschbaum Warren (Kemah TX) Weinberg Steven L. (League City TX), Intravaginal device and method for delivering a medicament.
Spicer Darcy V. (Pasadena CA) Pike Malcolm C. (Long Beach CA), Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders.
Peery John R. ; Dionne Keith E. ; Eckenhoff ; deceased James B. ; Landrau Felix A. ; Lautenbach Scott D. ; Magruder Judy A ; Wright Jeremy C., Sustained delivery of an active agent using an implantable system.
Quan Danyi (Salt Lake City UT) Deshpanday Ninad A. (Salt Lake City UT) Venkateshwaran Srinivasan (Salt Lake City UT) Ebert Charles D. (Salt Lake City UT), Triacetin as a penetration enhancer for transdermal delivery of a basic drug.
Quan Danyi ; Deshpanday Ninad A. ; Venkateshwaran Srinivasan ; Ebert Charles D., Triacetin as a penetration enhancer for transdermal delivery of a basic drug.
Devlin, Brid; Holt, Jonathon Daryll; Brimer, Andrew Nathan; Nuttall, Jeremy Peter; Malcolm, Karl; Fetherston, Susan Margaret; Boyd, Peter John James, Combination therapy intravaginal rings.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.